BRIP1 and lymphoma: Surprisingly, the lymphoma-free median survival age, although late in life, was significantly decreased in Fancj−/− mice (Fig. 3H), with 26% of Fancj−/− mutants developing lymphomas compared with ∼10% in littermate controls (Fig. 3I).